Priority to Cryopreservation Strategy (PCS) in IVF-ICSI Cycles
NCT ID: NCT03913208
Last Updated: 2023-07-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
1000 participants
INTERVENTIONAL
2019-05-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Does Transfer of Poor-quality Embryos With Good-quality Embryos Improve Pregnancy Outcome in Women Undergoing IVF/ICSI?
NCT03113097
Synchronizing Blastocyst in Frozen Embryo Transfer
NCT03128970
Does Preimplantation Genetic Diagnosis for Sex Selection Affect the Pregnancy and Miscarriage Rates in Women With an Expected Good Ovarian Response Undergoing IVF/ICSI Cycles?
NCT02149251
Comparison Between Biopsied and Non-biopsied Intracytoplasmatic Sperm Injection (ICSI) Embryos and Natural Pregnancy Embryos
NCT04280757
Extended Culture of Day 3 to Day 5 Frozen Thawed Day 3 Embryos Versus Day 5 Frozen-Thawed Embryos
NCT05858333
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study group
Will be subjected to priority to freeze
Priority to freeze
Priority for cryopreservation and later on embryo transfer in artificial cycle with endometrium preparation by the exogenous administration of estrogen-progesterone.
Control group
Will receive fresh embryo transfere
Fresh embryo transfer
usual strategy of giving the priority for fresh embryo transfer
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Priority to freeze
Priority for cryopreservation and later on embryo transfer in artificial cycle with endometrium preparation by the exogenous administration of estrogen-progesterone.
Fresh embryo transfer
usual strategy of giving the priority for fresh embryo transfer
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Presence of good number of embryos \> 5
Exclusion Criteria
* Low ovarian reserve
* Low number of embryos
20 Years
35 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tanta University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ayman S Dawood, MD
Lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ahmed Elhalwagy, MD
Role: STUDY_DIRECTOR
Tanta Universit
Yaser Mesbah, MD
Role: STUDY_CHAIR
Mansiura University
Ahmed Abbas, MD
Role: STUDY_CHAIR
Assiut University
Ahmed Elsawaf, MD
Role: STUDY_CHAIR
Cairo University
Shereef Elshowaikh, MD
Role: STUDY_CHAIR
Tanta University
Abdelghaffar Dawood, MD
Role: STUDY_CHAIR
Tanta University
Ahmed Elkhyat, MD
Role: STUDY_CHAIR
Tanta University
Shereen Elbohoty, MD
Role: STUDY_CHAIR
Tanta University
Waleed Mamdouh, MD
Role: STUDY_CHAIR
Tanta University
Mahmoud Soliman, MD
Role: STUDY_CHAIR
Cairo University
Waleed Tawfeek, MD
Role: STUDY_CHAIR
Benha University
Ahmed Saber, MD
Role: STUDY_CHAIR
Benha University
Amr Abdelrahman
Role: STUDY_CHAIR
Zagazig University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ayman Shehata Dawood
Tanta, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ahmed Elhalwagy
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PCS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.